An excerpt of BCLC strategy for prognosis prediction and treatment recommendations： The 2026 update
- VernacularTitle:《巴塞罗那肝癌临床分期预后评估与治疗推荐策略： 2026更新版》摘译
- Author:
Jihua XUE
1
;
Qingfen YE
2
;
Yinying LU
3
Author Information
- Publication Type:Journal Article
- Keywords: Carcinoma， Hepatocellular; Barcelona Clinic Liver Cancer Staging; Prognosis; Patient Selection; Clinical Decision-Making
- From: Journal of Clinical Hepatology 2026;42(8):1826-1830
- CountryChina
- Language:Chinese
- Abstract: The Barcelona Clinic Liver Cancer （BCLC） system is a major international framework for hepatocellular carcinoma prognostic assessment and treatment decision-making. While preserving the overall architecture of the 2022 edition， the 2026 update integrates the latest research evidence in locoregional therapy， systemic therapy， and liver transplantation， emphasizes a direct correspondence between staging and evidence-based first-line treatment options， and highlights the refined assessment of liver function， individualized decision-making， and pathway optimization in complex scenarios. This article gives an excerpt of the core concepts， key definitions， and key points regarding first-line treatment options for different stages in the 2026 update， with brief comments on the clinical practice in China.
